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Abstract
Background: The serine protease autotransporter EspP is a proposed virulence factor of Shiga toxin-producing Escherichia
coli (STEC). We recently distinguished four EspP subtypes (EspPa, EspPb, EspPc, and EspPd), which display large differences
in transport and proteolytic activities and differ widely concerning their distribution within the STEC population. The
mechanisms underlying these functional variations in EspP subtypes are, however, unknown.
Methodology/Principal Findings: The structural basis of proteolytic and autotransport activity was investigated using
transposon-based linker scanning mutagenesis, site-directed mutagenesis and structure-function analysis derived from
homology modelling of the EspP passenger domain. Transposon mutagenesis of the passenger domain inactivated
autotransport when pentapeptide linker insertions occurred in regions essential for overall correct folding or in a loop
protruding from the b-helical core. Loss of proteolytic function was limited to mutations in Domain 1 in the N-terminal third
of the EspP passenger. Site-directed mutagenesis demonstrated that His
127, Asp
156 and Ser
263 in Domain 1 form the catalytic
triad of EspP.
Conclusions/Significance: Our data indicate that in EspP i) the correct formation of the tertiary structure of the passenger
domain is essential for efficient autotransport, and ii) an elastase-like serine protease domain in the N-terminal Domain 1 is
responsible for the proteolytic phenotype. Lack of stabilizing interactions of Domain 1 with the core structure of the
passenger domain ablates proteolytic activity in subtypes EspPb and EspPd.
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Introduction
Gram-negative bacteria have developed various pathways to
secrete proteins into their milieu. Among the mechanisms
characterised, the autotransporter, or Type V secretion pathway
is apparently the simplest. The N-terminal signal peptide is
required for the recognition by the sec machinery which
mediates the transport through the inner membrane, whereas
the b-domain at the C-terminus of the autotransporter inserts
into the outer membrane and facilitates the secretion of the
transported passenger domain to the extracellular milieu [1].
More than 800 different autotransporters are known, forming
the largest group of secreted proteins in Gram-negative bacteria
[2,3].
The serine protease autotransporters of Enterobacteriaceae
(SPATE) constitute a subfamily of autotransporters that secrete
passenger domains displaying serine protease activity. SPATE
proteins have, with some exceptions [4], only been identified in
pathogens and are among the predominant proteins secreted by
these organisms [5], underlining their potential role in pathogen-
esis. Though sharing similar structural features, the SPATE
proteins appear to be functionally diverse [6].
EspP (extracellular serine protease, plasmid-encoded) is a
member of the SPATE family encoded on the large virulence
plasmids of Shiga toxin (Stx)-producing Escherichia coli (STEC) [7].
STEC are emerging pathogens worldwide and, like the best
known member of this group, E. coli O157:H7, cause a spectrum
of diseases ranging from uncomplicated diarrhoea to haemor-
rhagic colitis (HC) and the life-threatening haemolytic uraemic
syndrome (HUS) [8,9]. Although Stxs are considered cardinal
virulence traits of this group of organisms, additional virulence
factors contribute to the pathogenesis of STEC infections [8,10–
12]. One such factor is EspP, one of the most abundant proteins in
culture supernatants of STEC strains [5, Brockmeyer, unpublished
observation].
EspP cleaves coagulation factor V in human plasma [6,7], and
has been used as prototype to analyse different aspects of
autotransportation in recent years. This work demonstrates the
complexity of the mechanistic details of this secretion pathway
[13–15].
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6100We have recently studied the distribution, biological activity and
structural aspects of EspP in a large collection of STEC clinical
isolates and distinguished four subtypes of EspP (a, b, c and d).
These isoforms differ substantially in their structure and functions
[16]. EspPa (produced mainly by serotypes associated with severe
disease including HUS [17]) and EspPc are highly proteolytic and
efficiently autotransported. EspPb and EspPd were either not
secreted or were proteolytically inactive. These findings provide an
opportunity to determine the critical modifications in the EspP
subtypes that contribute to these phenotypes. We have therefore
conducted transposon-based linker permissive mutagenesis and site-
directed mutagenesis to map regions crucial for transport or
proteolytic activity throughout EspP. Homology modelling of the
EspP passenger was applied for the structure-based analysis of
respective mutants to gain a deeper understanding of the molecular
mechanisms underlying proteolytic and autotransport activity in
general and loss of function in EspP subtypes in particular.
Results
Generation of EspP transposon mutants
To analyse structure-function relationships, EspP clone DH5a/
pB9-5 [7] was subjected to permissive linker transposon mutagen-
esis to generate mutants harbouring in-frame 15 bp insertions at
different positions of espP. We obtained 45 transposon mutants
with in-frame insertion in the open reading frame of espP, resulting
in a pentapeptide linker of the corresponding mutant protein. The
linker insertions were distributed almost randomly over the
holoprotein, but with a diminished number of mutants within
the b-domain, as evidenced by nucleotide sequencing (Table 1 and
Fig. 1).
Effect of linker insertions on secretion efficiency
Fourteen of the 45 transposon mutant constructs displayed
severely reduced (80%–100%) secretion as evidenced by protein
immunoblot analysis of culture supernatants. The insert positions
in the secretion-deficient constructs were not distributed evenly
over EspP but accumulated in three distinct parts of the protein.
Eight of 14 secretion-deficient constructs sustained inserts in the C-
terminal part of the passenger domain or the N-terminus of the b-
domain (Fig. 1A). In two constructs without transport activity,
inserts were localised to the interfacing region separating signal
peptide and the N-terminal passenger domain. In the remaining
constructs, the linker was located in the central part of the
passenger domain (from amino acid 420 to 660) (Fig. 1A). In
accordance with the findings of Brunder and colleagues [7] we
were not able to detect intracellular amounts of EspP in DH5a/
pB9-5 suggesting that expression of the protein is followed by rapid
secretion. In contrast, the secretion-incompetent linker mutants
Y52, K429, H522, L920 and S1012 displayed detectable
intracellular amounts of the passenger domain of EspP indicating
accumulation of the protein in the late steps of biogenesis (data not
shown).
Table 1. PhenotypesandinsertpositionsofEspPlinkermutants.
Insert position
in mutant
Secretion
competence
Proteolytic
activity
K37 NN
Y52 # NA
E99 # NA
V159a N #
V159b N #
G175 N A
I217 N A
I246 N #
N311 N #
N329 NN
D362a NN
D362b NN
G380 NN
R421 A N
K429 # NA
V500 NN
T504 NN
N519 NN
H522 # NA
Y575 NN
M588 NN
N613 NN
T631 NN
Q659 A N
D669 NN
N690 NN
T709 NN
N772 NN
Y779a NN
Y779b NN
D790 A N
K832 NN
T858 NN
V898 A N
L920 # NA
K956 NN
Q968 NN
S973 # NA
A1007 A N
S1012 # NA
N1020 # NA
M1046 # NA
L1192 NN
N1271a NN
N1271b NN
Constructs are listed in order from N- to C-terminus of the EspP holoprotein.
Nomenclature of mutants is according to the insert position of the 5 amino acid
linker in the primarysequence ofEspP.Mutants designated ‘‘a’’and‘‘b’’represent
independent insertions at identical amino acid positions. The resulting
phenotype is illustrated as follows:N active, # inactive, A residual activity of
,10–20%. NA, not applicable because of absent secretion competence.
doi:10.1371/journal.pone.0006100.t001
Table 1. Cont.
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The effects of linker insertions on proteolysis were determined in
the 36 transposon mutants where EspP was found in culture
supernatants (Table 1). Loss of proteolytic activity was restricted to
constructs with insertions in the N-terminal third of the passenger
domain. All mutants harbouring their inserts between Val
159 and
Asn
311 displayed reduced proteolytic activity against the well
characterised EspP substrates porcine pepsin A [7] and the
chromogenic oligopeptide Ala-Ala-Pro-Leu-pNA [6]. Constructs
G175 and I217 retained residual activities of ,20%, but mutants
V159, I246 and N311 lacked all proteolytic activity (Fig. 1B),
indicating that the structural basis for proteolytic activity is
encoded solely within this region.
Taking into account that the proteolytic activity of serine
proteases is, in general, mediated by catalytic triads consisting of
aspartic acid, histidine and serine residues [18,19] we sought to
elucidate the position of the catalytic triad in the EspP passenger
domain. Fink and colleagues previously identified the catalytic
triad in the Hap autotransporter of Hemophilus influenzae and
demonstrated that this motif is conserved among related
autotransporters displaying serine protease activity [20]. We
aligned therefore the N-terminal third of the passenger domain
of EspP with Hap to determine sequence conservation within this
region using the AlignX tool in Vector NTI software package
(Invitrogen Inc., Karlsruhe, Germany) (data not shown). This
alignment demonstrated identical amino acid composition of Hap
and EspP at positions forming the active centre of Hap (His
98,
Asp
140 and Ser
243), indicating, that the catalytic triad of EspP
might be encoded at the respective positions (His
127, Asp
156 and
Ser
263) of the EspP passenger domain. To pursue these findings
experimentally, we conducted site-directed mutagenesis of the
corresponding residues to alanine and assessed the proteolytic
activity of the resulting EspP mutants. All three constructs
(H127A, D156A and S263A, respectively) completely lacked
proteolytic activity, further substantiating that His
127, Asp
156 and
Ser
263 form the active centre of the EspP passenger domain.
Interestingly, the nonproteolytic mutant N311 contains the
linker insertion next to point mutations Y313F and N316K, which
we identified previously in all proteolytically inactive samples of
EspPb and EspPd [16]. We performed site-directed mutagenesis to
determine if these mutations underlie the proteolytic inactivity in
these EspP subtypes. The double mutant Y313F/N316K showed
severely reduced (,45%) proteolytic activity when compared to
wild- type EspP from DH5a/pB9-5, underlining that these
alterations contribute significantly to the loss of proteolytic activity
in EspPb and EspPd.
Homology modelling of the EspP passenger domain
To gain insight into the structural properties responsible for the
functional differences between wild-type and mutant EspP
proteins, we employed homology modelling of the passenger
domain of EspP and used the resulting structure as a template to
analyse the structure-function relationships in EspP. Comparative
homology modelling is, however, challenging when sequence
identity of the template and target is ,30% [21,22]. Furthermore,
protein structures have been resolved for only few autotransporters
[23–26] and only one SPATE protein, Hbp (haemoglobin
protease) [27]. Recently, Fernandez-Fuentes et al. described an
iterative algorithm to comparatively model target proteins with
low sequence identity to the template [28]. This approach enabled
us to create an overall consistent model of EspP as evidenced by
evaluation of model quality (Table S1, supplementary material).
Figure 1. Representation of EspP linker mutants inserts and phenotypes. A. Insert position and transport activity of linker mutants.
Immunoblot of concentrated culture supernatants of wild-type EspP (strain DH5a/pB9-5) and secretion-incompetent linker mutants where only trace
amounts or no EspP was detectable. The EspP autodegradation band is indicated by asterisk. Insert positions of single mutants within EspP
holoprotein are symbolized by pins, transport activity is indicated by colour code (black: transport activity comparable to wild-type, grey: residual
activity (,10–20%), white: loss of transport activity). Mutants displaying loss of function are indicated by construct names. B. Linker mutants assayed
for proteolytic activity. Activity of single mutants is illustrated by colour code (see A for description), and construct names of inactive mutants are
indicated.
doi:10.1371/journal.pone.0006100.g001
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chosen template Hbp, the resulting model displays large
similarities when compared with the structure of Hbp. The
predicted EspP structure harbours an extensive slightly kinked b-
helical structure C-terminal from Tyr
315 of the primary sequence
of the holoprotein with 23 right-handed beta-roll turns (Hbp: 24)
(Fig. 2). In contrast to Hbp, the b-helix is interrupted at Lys
722,
leading to a constriction at this position. The N-terminal fourth
forms a distinct large globular domain which is connected to the
C-terminal part of the passenger domain at position 315 and is in
close contact with the b-helix via several loop regions. A second
globular domain protrudes from the b-helical stem between
positions 515 and 562. The corresponding domain in Hbp is 75
amino acids in size [27], slightly larger than in the EspP model and
includes, in contrast to EspP, an aromatic binding pocket
suggesting different functionality. According to the nomenclature
of the corresponding globular domains in the template Hbp, we
designated the large and the small globular domain in the EspP
model Domains 1 and 2, respectively (Fig. 2).
Structural analysis of secretion-ablating mutations in
EspP passenger domain
i) Secretion-deficient mutants in the N-terminal part of
the passenger domain. Inserts in transport deficient mutants
in the N-terminal half of the passenger domain (E99 and K429)
are located in proximity in the EspP model despite their remote
insert positions in primary sequence. Insert K429 is predicted to be
located in the b-helical stem directly facing globular Domain 1,
whereas insertion of construct E99 is within Domain 1 adjacent to
a loop, which is closely apposed to the opposite b-helix (Fig. 3A).
In accordance with its position in the primary sequence of EspP,
we designated this region loop 165. Residues up- and downstream
of this loop are predicted to be threaded closely through the
neighbouring regions of Domain 1, most probably stabilising the
structure. One of the major interactions in the model structure is
thereby formed by a salt bridge between Asp
104 and Arg
170
upstream of loop 165 (Fig. 3B). Loop 165 itself forms a complex
salt bridge with the opposing b-helix, where the residues Lys
164
and Glu
168 interact with Asp
408 and Lys
429, respectively. His
411,
located in the centre of the salt bridge, is presumed to further
stabilise the interaction (Fig. 3B).
To further evaluate these findings and to assess if this structural
feature is conserved within the SPATE family, we built a model of
the related passenger domain of Pet (plasmid-encoded toxin of
enteroaggregative E. coli) and compared the structural properties
of EspP, Pet and the Hbp crystal structure, as well as sequence
conservation of the SPATE proteins within this region. All
structures displayed a loop region similar to loop 165 of EspP,
forming intimate contact to the neighbouring b-helix via salt
bridges (Fig. S1A). Furthermore, key residues presumed to be
involved in stabilization of the loop region and formation of salt
bridges between loop 165 and b-helix are highly conserved among
members of the SPATE family, whereas sequence conservation of
the surrounding regions is less pronounced (Fig. 3C). Insert
position in the secretion incompetent construct E99 is juxtaposed
to the highly conserved sequence DFS at positions 104–106
(Fig. 3C), where Asp
104 is predicted to form a salt bridge with
Arg
170 stabilizing loop 165. We assume that the linker insertion at
this position causes localised misfolding and lack of stabilizing
interactions with loop 165 leading to impaired contact between the
b-helical stem and the globular Domain 1. The insert in the
transport-deficient construct K429 is in a conserved sequence
motif directly involved in the formation of the salt bridge with loop
165, whereas the insert position in R421, which shows residual
transport activity, is on the contralateral side of the b-helix.
Mutants where insertions occurred on either side of this region
showed no loss of transport activity (Fig. 3A), suggesting a specific
interaction between loop 165 and this part of the b-helical stem.
Taken together, these results suggest that the interaction of the
globular Domain 1 with the b-helical stem mediated by loop 165 is
an overall conserved structural feature of SPATE proteins essential
for the efficient secretion of the passenger domain. These findings
are further supported when we display results of a similar
mutagenesis approach recently applied to the related autotran-
sporter Pet [29] on our Pet homology model. Both linker inserts
leading to the lack of transport activity within the N-terminal half
of the passenger domain reported in that study (I114 and A452,
respectively) are located in close proximity of the respective
transport-deficient constructs of EspP. Similar to EspP, insert I114
is situated in a conserved region presumed to stabilize loop 165,
whereas construct A452 occurs in the opposing b-helix region (Fig.
S1B).
Figure 2. EspP homology model. Ribbon diagram (blue) with overlaid surface displaying the overall structure of the homology model of the EspP
passenger. Domains 1 and 2 as well as the b-helical stem are indicated. Interface of Domain 1 and b-helix at position 315 and constriction within the
helix at position 722 of the primary sequence of EspP are highlighted.
doi:10.1371/journal.pone.0006100.g002
EspP Structure and Function
PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6100ii) Linker insertions in Domain 2 leading to loss of
secretion. Mutant H522 in the central portion of the EspP
passenger domain displays loss of autotransport activity (Fig. 1A),
whereas mutants with insertions in surrounding regions
demonstrated normal secretion efficiency. Notably, the insert in
H522 is in the small globular Domain 2 of the EspP model,
whereas the neighbouring mutants are located in the adjacent b-
helix (Fig. 4A). To confirm these findings and to investigate more
broadly if SPATE proteins are susceptible to alterations in
Domain 2 concerning autotransport activity, we again overlaid
the recent mutagenesis study of Pet [29] on our Pet model.
Analysis of the corresponding linker mutants provided results
comparable to EspP, with transport inactive Pet mutants T573,
A576 and F589 located within Domain 2 of our Pet model, and
active mutants in the flanking b-helical core region (Fig. 4B).
Alignment of the corresponding sequences encoding Domain 2
displayed, however, a pronounced heterogeneity among the
SPATE proteins, suggesting different functions of this part of the
passenger domain (data not shown). We noted that the positions of
Domain 2 are slightly shifted in the models of EspP and Pet. While
in EspP Domain 2 is formed by amino acid 515–562, in Pet
residues 571–629 are involved in the formation of this domain.
Though a modelling artefact cannot be excluded as an explanation
for this difference in view of the low sequence similarity to the
template Hbp, our finding of transport-deficient Pet and EspP
mutants localised in Domain 2 of both proteins and active mutants
in the surrounding regions supports the obtained modelling data.
In conclusion, the data suggest that minor alterations in the
exposed Domain 2 are critical for the autotransport phenotype of
SPATE proteins.
iii) Secretion-deficient mutants in the C-terminal part of
the passenger domain. The C-terminal 100 amino acids of
the EspP passenger domain accumulated an abundance of
transport-incompetent mutants. This region has been proposed
to play a decisive role in autotransport activity, and has been
termed linker region [30–32]. Alignment of this part of the
passenger domain in our model illustrated an increase in sequence
conservation among proteins of the SPATE family compared to
the N-terminal part, further indicating that this region might
encode a shared functional aspect. Display of conserved residues
on the EspP model demonstrates, however, that sequence
conservation was not distributed equally in the C-terminal part
of the EspP passenger, but accumulated mostly in stacked residues
within flanks of the b-helix and the C-terminal end of the
passenger domain (Fig. 5A). Comparison of insert positions and
sequence conservation within the C-terminal linker region
demonstrated that mutants harbouring inserts at positions of
overall conservation showed loss of transport activity, whereas
Figure 3. Transport activity of inserts in the N-terminal part of the passenger domain. A. Ribbon diagram of junction between Domain 1
and b-helix. Localization of this region is illustrated in the overview of the passenger domain. Insert positions of linker mutants in the junction are
highlighted by coloured spheres, indicating transport activity of the respective constructs (red: transport-inactive, yellow: residual activity, green:
activity comparable with wild-type). Constructs displaying loss of function are highlighted by construct names. Loop 165 is marked in orange. B.
Detailed representation of interactions leading to stabilisation of the junction region (twofold magnification, view rotated 180u). Salt bridges are
indicated by dashed lines, residues involved in stabilising interactions are named and illustrated in stick representation. Loop 165 is given in orange.
C. Sequence alignment of residues in SPATE proteins forming the junction region. Overall conserved residues are highlighted in orange. Residues
mediating inter-domain interactions as described in B are named and marked by black frames. Key residues involved in interaction are highly
conserved in SPATE proteins.
doi:10.1371/journal.pone.0006100.g003
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PLoS ONE | www.plosone.org 5 July 2009 | Volume 4 | Issue 7 | e6100Figure 4. Transport activity of insertions in the central part of the passenger domain. A. Linker inserts surrounding Domain 2 in EspP are
depicted as coloured spheres. Transport active constructs are illustrated in green, secretion-incompetent mutants are marked red. Insert H522 in the
loop of Domain 2 leads to loss of autotransport activity, whereas neighbouring inserts in the b-helical stem do not influence secretion competence. B.
Display of mutagenesis results from Dutta et al. (2003) on our Pet model. Insertions in the respective Domain 2 lead to loss of transport functionality,
while insertions in the b-helix core are permissive to transport activity. Localisation of Domain 2 within the passenger domain structure is exemplified
for EspP.
doi:10.1371/journal.pone.0006100.g004
Figure 5. Sequence conservation and transport activity of constructs in the C-terminus of the passenger domain. A. Sequence
conservation in linker region of the passenger domain. Residues displaying overall sequence identity are coloured in red, sites showing at least 80%
sequence similarity are given in orange. B. Insert positions in transposon mutants highlighted as coloured spheres. Transport-active constructs are
illustrated in green, secretion-incompetent mutants are marked in red and constructs displaying residual transport activity are coloured yellow. Insert
position is given for transport-inactive constructs.
doi:10.1371/journal.pone.0006100.g005
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compatible with autotransport activity (Fig. 5B).
We therefore determined if conservation of key residues
correlates with surface properties of the SPATE proteins, but
there was no consistent motif when comparing hydrophobicity
and/or charge of the respective linker regions of EspP, Pet and
Hbp (data not shown). We conclude therefore that conservation of
the overall structure, rather than specific surface properties, is
crucial to preserve autotransport activity of the linker region.
Interestingly, we noted that several transport-deficient transpo-
son mutants harboured inserts near a unique point mutation
present in the espPb gene of the recently characterized strain 89/
04 [16]. Though the corresponding EspP protein of this strain
differs only in the point mutation R1005Q from other members of
the EspPb subtype, we were not able to detect, in contrast to other
samples from this subtype, EspP protein in the supernatant of this
strain. However, a R1005Q site-directed mutant in pB9-5 did not
diminish transport activity, indicating that other factors might be
responsible for the lack of extracellular EspP in strain 89/04.
Indeed, espPb in strain 89/04 is not transcribed as evidenced using
reverse transcription (RT)-PCR, suggesting that the prime defect
in non-secretion of EspP is absence of gene expression, rather than
altered protein sequence.
Structural analysis of transport-deficient mutants in b-
domain
Using linker scanning mutagenesis, we obtained three mutants
(M1046, L1192 and N1271) in the b-domain, the C-terminal part
of the EspP holoprotein involved in transport through the outer
bacterial membrane. Using the recently solved structure of this
domain [14], we demonstrated that the transport-deficient mutant
M1046 harbours the linker insert in the first b-sheet, whereas both
constructs displaying normal transport activity (L1192 and N1271)
show linker insertions within loop regions (Fig. 6). These data
underline the crucial role of a correctly folded b-barrel for
autotransport of EspP, whereas loop regions within the b-domain
are more tolerant to structural alterations.
Structural properties of proteolytic activity of theEspP
passenger
To verify our finding that His
127, Asp
156 and Ser
263 form the
catalytic triad of EspP, we displayed the positions of the three
amino acids on the homology model of EspP. This demonstrat-
ed that all these residues are located in close proximity on the
surface of Domain 1, underlining their role in the formation of
the active centre of EspP (Fig. 7A). Transposon mutants were
proteolytically inactive when inserts were located near the
catalytic triad. Mutants G175 and I217, which showed residual
proteolytic activity, harboured the linker insert further from the
active centre in the model structure, supporting our observation
that the loss of proteolytic activity is only observed when
structural alterations occur close to the active centre (Fig. 7A).
To our surprise, the proteolytically inactive transposon mutant
N311, and the site-directed double mutant Y313F/N316K,
mimicking the alterations presumably responsible for the lack of
proteolytic activity in EspPb and EspPc [16], are located in the
region interfacing Domain 1 and the b-helical core directly
downstream the linking a-helix of the model structure. In
addition, we noted that Arg
161 upstream Asp
156 and Tyr
121
downstream His
127 are predicted to contact with residues in this
interfacing region, suggesting that these interactions might
contribute to functional positioning of residues Asp
156 and
His
127 as parts of the active centre (Fig. 7B). Arg
161 is conserved
in all SPATE passenger domains (see also Fig. 3C, sequence
conservation of loop 165) and is predicted to build a salt bridge
with Asp
346, whereas Tyr
121 interacts via hydrogen bonds with
Lys
312 and Tyr
313 (Fig. 7B). These results suggest that His
127
and Asp
156, involved in the formation of the catalytic triad of
EspP, are stabilised by interactions with the interfacing region
between Domain 1 and the b-helix. Decreased proteolytic
activity of mutants N311 and Y313/N316K might therefore be
caused by improper formation of the catalytic triad as a result of
reduced stabilizing hydrogen bonds between Tyr
121, Lys
312 and
Tyr
313.
Discussion
We used a combination of mutagenesis techniques and
homology modelling to gain insight into mechanisms underlying
functional variations in the previously identified EspP subtypes
[16]. This approach allowed the identification of critical
modifications in the EspP subtypes b and d leading to lack of
proteolytic activity. Both mutations, Y313F and N316K, have
been observed in all characterised samples of the above subtypes,
whereas none of the proteolytically active subtypes, EspPa or
EspPc, harboured these modifications [16]. It is, however,
noteworthy that the corresponding double mutant Y313F/
N316K only incompletely reproduces the phenotype observed in
EspPb and EspPd. EspP proteins of the respective subtypes
Figure 6. Transport activity of linker inserts in the b-domain.
Three linker mutants locate inserts in the b-barrel of EspP as indicated
by coloured spheres. Inserts within loop regions were permissive to
transport (illustrated green), while insertion in the central part of the
barrel lead to loss of transport activity (indicated red).
doi:10.1371/journal.pone.0006100.g006
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activity [16], whereas mutant Y313F/N316K demonstrated
reduction of activity of approximately 50%. It is therefore likely
that further modifications might contribute, though indirectly, to
the observed phenotype in STEC strains. In contrast, lack of
secretion of EspPb from the prototype strain 89/04 [16] does not
result from modifications on protein level, but is caused by
impaired gene expression. This finding might provide a fundament
for the analysis of regulatory elements of EspP in future studies.
Concerning the effect of linker insertions on secretion efficiency
of EspP in general, we observed that mutations in three different
and definable regions of the folded passenger ablated the secretion
phenotype. First, mutants showing linker insertions within a
limited junction region between Domain 1 and the nearby b-helix
were no longer able to perform autotransport, whereas inserts
juxtaposed to this region did not affect this function. These results
suggest that formation of a compact tertiary structure, mediated by
different noncovalent interactions between loop 165 in Domain 1
and b-helix, contributes to the efficient secretion of the passenger
domain to the extracellular compartment. Interestingly, paired
cysteine mutants in Hbp covalently connecting Domain 1 and b-
helix by newly introduced disulphide bridges in the junction region
eliminate autotransport activity [33]. Consequently, it has been
assumed that either tolerance towards folding is limited or
flexibility of a folded passenger domain plays an important role
for secretion. Based on our findings, we favour the hypothesis that
the passenger domain folds at least at one step during secretion
and that stabilizing interactions between the folded Domain 1 and
b-helix are indispensable. Furthermore, the obtained tertiary
structure obviously needs to maintain a certain degree of flexibility
as provided by the relatively weak interactions mediated via salt
bridges. In contrast to that, covalent binding of the folded
domains, as mediated by proximal cysteine mutants, are
incompatible with autotransport.
Our hypothesis that folding is critical for the secretion of the
passenger domain was further supported by the observation that
insertions within Domain 2 also lead to the loss of transport
function, whereas modifications in the surrounding b-helical stem
did not. The finding that minor alterations of the small Domain 2
(introduction of 5 residues in a domain of ,50 amino acids)
influence secretion was unexpected as we assume that the overall
modification of the tertiary structure is minimal. While loss of
interactions between Domain 1 and b-helix are presumed to
substantially change folding of the passenger domain, the effects of
linker inserts in the protruding Domain 2 are most probably only
local. A direct involvement of Domain 2 in autotransport is,
however, rather unlikely, because this part shows only low
sequence similarity among SPATE proteins, suggesting that no
shared functional feature is encoded in this part of the protein.
Moreover, deletion mutants lacking Domain 2 have been reported
to be secreted efficiently [32–34]. Our findings were confirmed for
Pet when we displayed the corresponding linker mutants reported
by Dutta and colleagues [29] on our Pet model. Linker insertions
in Domain 2 of Pet also prevented secretion, suggesting that a
(potentially conserved) functional aspect in the autotransport
mechanism of SPATE proteins is susceptible to alterations of
exposed regions like Domain 2.
In this context, the recently discovered Omp85/YaeT complex,
essential for the integration of b-barrel proteins (including
autotransporters) in the outer membrane [35,36], might play a
yet unknown role in the autotransport secretion process. A
recently proposed model hypothesized that Omp85/YaeT is not
only involved in the formation of the integration-competent folded
state of autotransporter b-domains, but furthermore contributes to
Figure 7. Analysis of proteolytic activity in Domain 1. A. Left: Display of the catalytic triad on the surface of Domain 1. Residues forming the
active centre are given as sticks and coloured orange. All residues of the catalytic triad are surface exposed. Right: Insert positions of linker in Domain
1 are marked by coloured spheres indicating the proteolytic activity of the respective constructs. Red spheres symbolise complete loss of activity in
the corresponding construct; yellow spheres indicate highly reduced residual activity. Residues forming the catalytic triad are shown as orange sticks.
B. Interaction between Domain 1 and the interfacing a-helix. Residues involved in stabilisation of His
127 (Tyr
121, Lys
312 and Tyr
313) are shown as yellow
sticks, amino acids mediating stabilisation of Asp
156 (Arg
161 and Asp
346) are given in red.
doi:10.1371/journal.pone.0006100.g007
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membrane [37]. This model is in accordance with the observation
that the pore size (,2.5 nm) of the Omp85/YaeT complex is large
enough to allow the translocation of at least partially folded
proteins [38].
The C-terminal linker region of passenger domains has been
proposed to be fundamental for autotransport activity of a variety
of proteins [30–32,39,40]. Conserved residues, localization of
autotransport-deficient mutants, and analysis of surface properties
in our study provide data that conservation of structural elements,
rather than surface characteristics per se, is crucial for autotran-
sport functionality in this region. A recent study suggested that
hydrophobic residues of the EspP linker domain are essential for
the outer membrane transport [32]. Display of secretion
incompetent mutants obtained in that study on our EspP model
demonstrates, however, that mutations mostly occurred in b-sheets
of the EspP linker domain. Moreover, most alterations in
transport-incompetent mutants changed hydrophobic residues to
proline, which is known to be deleterious for the formation of b-
sheets [41,42]. We propose therefore that inhibition of formation
of b-sheets rather than changed hydrophobicity causes loss of
autotransport activity in the linker region.
Notably, the C-terminal end of the EspP passenger resembles to
a certain extend the POTRA (polypeptide-transport-associated)
domains of the TpsB protein FhaC, the transport cofactor in the
two-partner secretion system of FHA (filamentous hemagglutinin)
[43]. Though the a-helical part typical of POTRA domains is
missing, the residual structure is similar with key residues
conserved among SPATEs forming the structural backbone. We
therefore hypothesize that the linker part of EspP might be
involved as a periplasmic autochaperone in folding or maturation
during secretion similar to the POTRA domain in the TpsB
proteins, which is, strikingly, also situated directly N-terminal to
the part forming the b-barrel.
In summary, our data demonstrate that constructs lacking
proteolytic activity are confined to the N-terminal third of the
EspP passenger domain. All proteolytically inactive mutations
were limited to the globular Domain 1, providing evidence that
this part of the passenger domain solely encodes the proteolytic
activity. The experimental confirmation of His
127, Asp
156 and
Ser
263 as residues forming the proteolytically active site in EspP
further supports the hypothesis that Domain 1 comprises a
classical serine protease with a catalytic triad as structural basis for
proteolytic activity. Employing the DALI server [44] to search for
structural homologues of Domain 1 revealed that residues 102–
313 are quite similar to porcine pancreatic elastase (PDB: 9est),
with a Z-score of 17.0 (scores .2.0 are considered significant),
suggesting that the proteolytic domain in the EspP passenger
might be elastase-like. Future studies will address, if EspP not only
shows structural similarities with elastases but also shares
functional aspects with this serine protease family.
Materials and Methods
Bacterial strains and plasmid constructs
E. coli K12 strain DH5a was host for all constructs used in this
study. Functional active EspP was obtained from clone DH5a/
pB9-5, which contains espP from STEC O157:H7 strain EDL933
[7].
Linker permissive transposon mutagenesis
Plasmid pB9-5 was subjected to randomized mutagenesis in
vitro with the Tn7-derived GPS-LS transposon using the GPS-LS
linker scanning system (New England Biolabs, Beverly, USA)
according to the manufacturer’s instructions. Briefly, purified
plasmid pGPS-4 was used as donor plasmid for the transposition
reaction to insert a chloramphenicol resistance cassette (Camp
r)
into pB9-5. The mutagenized plasmids were transformed into E.
coli DH5a that was incubated on Luria Bertani (LB) agar plates
containing kanamycin and chloramphenicol. Colonies grown on
selective media were selected for screening for insertions in the
open reading frame of espP and estimation of insert position
using PCR with one fixed forward primer (59-cgc tgt ttc tga att
atc cgg ca-39) annealing in the 39-end of the espP gene and two
primers annealing in the borders of the insertion element,
respectively (Tn-R, 59-act tta ttg tca tag ttt aga tct att ttg-39 and
Tn-L, 59-ata atc ctt aaa aac tcc att tcc acc cct-39). Plasmids from
constructs with (Camp
r) insert in the espP gene were purified
using Qiagen Spin Miniprep Kit (Qiagen, Hilden, Germany).
Plasmid DNA was subsequently digested with PmeI to remove
the chloramphenicol resistance gene and plasmid fragments were
separated by agarose gel electrophoresis, purified using the Prep-
A-Gene Kit (Bio-Rad, Hercules, USA), religated and trans-
formed into E. coli DH5a. Sequence analysis was conducted to
determine the position of the remaining 15 bp linker using
primer Tn-R and Tn- L. Based on sequence data, all constructs
have been analysed for in-frame insertion of the linker resulting
in a five amino acids prolonged EspP protein.
Site-directed mutagenesis
Site-directed mutagenesis was performed either using the Quick
change II XL kit (Agilent-Stratagene, Waldbronn, Germany) or
Phusion kit (New England Biolabs, Beverly, USA). Briefly, purified
plasmid pB9-5 was used as template for the Quick change II XL
protocol and amplified in a linear amplification reaction using the
mutagenic primers (H127A: f: 59-cag tat cac agc cac agc caa tac gaa
aaa cca cca ctc a-39 and r: 59-gtc ata gtg tcg gtg tcg gtt atg ctt ttt ggt
ggt gag t-39; D156A: f: 59-gaa tac ttc acatcc tgc ttt tgc agt atc ccg act
tga c-39 and r: 59-ctt atg aag tgt agg acgaaa acgtca tag ggc tga actg-
39; S263A: f: 59-cat tgc ctc tca ggg tga cgc cgg ttc agc act gtt cg-39
and r: 59-cga aca gtg ctg aac cgg cgt cac cct gag agg caa tg-39).
Template DNA was digested with DpnI and the newly synthesized
plasmid was transformed into E. coli DH5a using electroporation.
The Phusion kit was applied for constructs Y313F/N316K, and
R1005Q using mutagenic primers (Y313F/N316K: Y313F f: 59-tgg
ata tgt cag ggg ctc agg -39, and r: 59-cgt tgt aag aaa act tgt tct tca gg-
39; N316K f: 59-att ctt aca aag tgg ata tgt cag gg-39, and r: 59-act tgt
tct tca ggt tgt caa tgg-39; R1005Q f: 59-cgc cct gtt ctc tgt tga cta taa
ag-39, and r: 59-gcg gca ttc tgg gtt gct tcc t-39). Again, purified
plasmid pB9-5 was used as template for the amplification reaction.
PCR product was ligated using Quick T4 DNA ligase and
transformed into E. coli DH5a using electroporation according to
recommendations in Phusion manual. For each construct three
individual colonies were subjected to plasmid purification and
sequence analysis ensuring successful mutagenesis.
Purification of EspP from culture supernatants and
whole-cell extracts
For the purification from culture supernatants strains were
grown overnight in 100 ml of LB broth at 37uC with vigorous
shaking. The cultures were centrifuged (6,0006g, 30 min, 4uC)
and supernatants were passed through 0.20 mm pore-size filters
(Corning, Corning NY, USA). Proteins were precipitated (1 h,
4uC) by adding ammonium sulphate (Merck, Darmstadt, Ger-
many) to 55% saturation. The precipitate was collected by
centrifugation (6,0006g, 30 min, 4uC) and pellet was dissolved in
500 ml of 10 mM HEPES (N-2-hydroxyethylpiperazine-N’-2-
ethanesulfonic acid) buffer containing 150 mM NaCl (pH 7.4).
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Healthcare, Freiburg, Germany) according to the manufacturer’s
instructions. The fractions enriched for EspP were collected and
concentrated using 10 kDa Vivaspin spin-down filter (Vivascience-
Sartorius, Go ¨ttingen, Germany). For the analysis of EspP in
whole-cell extracts strains were grown in 25 ml LB broth to an
OD600 of 1.5, centrifuged (4,0006g, 20 min, 4uC), washed with
phosphate buffered saline and resuspended in 46Laemmli sample
buffer. Cells were sonicated three times for 1 min and boiled for
10 min at 99uC.
SDS-PAGE and immunoblotting
Detection of EspP in crude culture supernatants and purified
EspP samples was performed as described previously [16]. Briefly,
proteins were separated by SDS-PAGE, transferred to nitrocellu-
lose membrane (Schleicher & Schuell, Dassel, Germany) and
detected with rabbit anti-EspP antibody (diluted to 1:1.000) [7]
and a horseradish peroxidase-conjugated goat anti-rabbit antibody
(diluted to 1:40.000) (Dianova, Hamburg, Germany). Bound
antibodies were visualised by incubation with SuperSignal West
Pico chemiluminescent substrate (Pierce, Rockford, USA), fol-
lowed by the detection of the chemiluminescence signal using
ChemiDoc XRS imaging system (Bio-Rad, Mu ¨nchen, Germany).
The detection limit of the assay was $50 ng of protein. Detection
of EspP was performed in crude culture supernatants and the
purified samples, respectively, to rule out the possibility that EspP
was lost during purification. EspP from each construct was purified
and analysed in triplicate.
Analysis of proteolytic activity
One microgram of purified EspP was incubated (15 h at 37uC)
with a 2 mM solution of the para-nitroaniline-conjugated
oligopeptide substrate alanine-alanine-proline-leucine (Ala-Ala-
Pro-Leu-pNA) (Bachem, Weil am Rhein, Germany) in 10 mM
HEPES buffer with 150 mM NaCl, pH 7.4. Reactions were
performed in 96-well microtiter plates in total volumes of 100 ml.
The absorbance was determined at 0 min and 15 h at 405 nm
using a microplate reader (Dynex Technologies, Chantilly, USA).
Samples were defined as proteolytically active when the difference
of the absorbance readings was $0.03 units. The EspP-producing
clone DH5a/pB9-5 and the vector control strain DH5a (pK18)
without the espP insert were used as positive and negative control,
respectively. Three individual purifications of each construct were
analysed. For the analysis of proteolytic activity against porcine
pepsin A one microgram EspP was incubated with 25 mg pepsin A
for 15 h at 37uC. Substrate cleavage was analysed using SDS-
PAGE followed by Coomassie staining.
Homology modelling
Comparative homology modelling of the EspP passenger
domain was performed employing the M4T server [28]. The
modelling approach is based on an iterative algorithm for
automated target-to-template alignment followed by model
building using the MODELLER program [45] integrated in the
M4T package and subsequent structural optimization of the
obtained model. The sequence of the passenger domain of EspP
from STEC O157:H7 strain EDL933 [7] was used as target for
model building. The structure of Hbp (PDB: 1wxr) [27] was
chosen by M4T as template for modelling. Homology modelling of
the Pet passenger domain was performed accordingly, using the
sequence published by Eslava and coworkers [46]. Evaluation of
the obtained models was performed using ANOLEA [47],
Prosa2003 [48], PROCHECK [49] and QMEAN [50]. Figures
were prepared using Pymol (DeLano Scientific).
Two-step RT-PCR
STEC strains EDL933 (O157:H7) and 89/04 (O7:H18) were
inoculated into 30 ml of LB broth and grown at 37uC with
vigorous shaking (180 rpm) for approximately 150 minutes.
Bacteria were collected by brief centrifugation (20,0006g, 20uC)
and RNA was extracted using High Pure RNA Isolation kit
(Roche, Mannheim, Germany) according to the manufacturer’s
instructions. Two mg of bacterial RNA were treated with 1 mgo f
DNAse I (Stratagene, La Jolla, USA) for 15 min at room
temperature. Reverse transcription was performed by adding
1 ml of Superscript II (Invitrogen, Karlsruhe, Germany) and
incubation at 42uC for 50 minutes followed by incubation at 70uC
for 15 minutes. The reaction was stopped by chilling on ice.
Subsequently, 1 ml aliquots of the resulting cDNA were amplified
using primers EspP fwd (59-gct cca ccc tga aac tac cg-39) and EspP
rev (59-cgt tca agt gcc tgc tgt tt-39). gapA was used as a positive
control and was amplified using primers GapA fwd (59-gtt gtc gct
gaa gca act gg-39) and GapA rev (59-agc gtt gga aac gat gtc ct-39).
In negative controls, RNA was omitted from the cDNA synthesis
before PCR amplification. PCR products were separated in 2.0%
agarose gel and visualised by staining with ethidiumbromide.
Supporting Information
Figure S1 Interaction between loop 165 and b-helix is
conserved in SPATE proteins. A. Representation of interfacing
junction region in the SPATEs EspP, Hbp and Pet. Salt bridges
are marked with dashed lines, residues involved in formation of
stabilizing interactions are shown as sticks, and respective residues
are labelled. Key residues involved in interactions are conserved
on sequence level as indicated in Fig. 2 and display large structural
similarities. The respective loops 165 are marked in orange. B.
Linker insertion in junction region of Pet interferes with transport
activity. Inserts at positions preventing the correct formation of
junction region lead to loss of transport activity in Pet, as
evidenced by analysis in the homology model. Position of inserts in
the respective constructs is illustrated as red spheres (constructs
I114 and A452), surrounding linker mutants permissive to
secretion are illustrated in green. Data of the linker mutagenesis
study of Pet reported previously, (Dutta et al., 2003) have been
displayed on the Pet homology model.
Found at: doi:10.1371/journal.pone.0006100.s001 (10.04 MB
TIF)
Table S1 Evaluation of model quality. Evaluation of model
quality of EspP and Pet using Procheck and QMEAN. Both
programs confirm that valid models of EspP and Pet were
obtained with quality parameters comparable to the template
structure (PDB: 1wxr) derived from Hbp. Procheck parameters
display 82–86% of the residues in the most favoured region of the
Ramachandran Plot and less than 1% in disallowed regions with
only marginal differences between template and model scores. The
QMEAN program was used for comparison of model quality of
the obtained homology models. Scores of the chosen models of
EspP and Pet are comparable to the score for the template
structure Hbp.
Found at: doi:10.1371/journal.pone.0006100.s002 (0.03 MB
DOC)
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